Title : Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia.

Pub. Date : 2018 May 24

PMID : 29795382






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Retinoic acid (RA) and arsenic target the t(15;17)(q24;q21) PML/RARA driver of acute promyelocytic leukemia (APL), their combination now curing over 95% patients. Tretinoin PML nuclear body scaffold Homo sapiens
2 Retinoic acid (RA) and arsenic target the t(15;17)(q24;q21) PML/RARA driver of acute promyelocytic leukemia (APL), their combination now curing over 95% patients. Tretinoin PML nuclear body scaffold Homo sapiens
3 Accordingly, clonogenic activity of PML/RARA-immortalized progenitors ex vivo is only transiently affected by RA, but selectively abrogated by arsenic. Tretinoin PML nuclear body scaffold Homo sapiens